4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors

被引:28
作者
Beria, Italo [1 ]
Valsasina, Barbara [1 ]
Brasca, Maria Gabriella [1 ]
Ceccarelli, Walter [1 ]
Colombo, Maristella [1 ]
Cribioli, Sabrina [1 ]
Fachin, Gabriele [1 ]
Ferguson, Ronald D. [1 ,2 ]
Fiorentini, Francesco [2 ]
Gianellini, Laura M. [1 ]
Giorgini, Maria L. [1 ]
Moll, Jurgen K. [1 ]
Posteri, Helena [1 ]
Pezzetta, Daniele [2 ]
Roletto, Fulvia [1 ]
Sola, Francesco [1 ]
Tesei, Dania [1 ]
Caruso, Michele [1 ]
机构
[1] Nerviano Med Sci Srl, Business Unit Oncol, I-20014 Milan, Italy
[2] Accelera, I-20014 Milan, Italy
关键词
PLK1; Polo-like kinase; Kinase inhibitor; In vivo activity; CHECKPOINT; CANCER;
D O I
10.1016/j.bmcl.2010.09.060
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A series of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives was optimized as Polo-like kinase 1 inhibitors. Extensive SAR afforded a highly potent and selective PLK1 compound. The compound showed good antiproliferative activity when tested in a panel of tumor cell lines with PLK1 related mechanism of action and with good in vivo antitumor efficacy in two xenograft models after iv administration. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6489 / 6494
页数:6
相关论文
共 16 条
[1]
Polo-like kinases and the orchestration of cell division [J].
Barr, FA ;
Silljé, HHW ;
Nigg, EA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (06) :429-440
[2]
The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint [J].
Bassermann, Florian ;
Frescas, David ;
Guardavaccaro, Daniele ;
Busino, Luca ;
Peschiaroli, Angelo ;
Pagano, Michele .
CELL, 2008, 134 (02) :256-267
[3]
Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors [J].
Beria, Italo ;
Ballinari, Dario ;
Bertrand, Jay Aaron ;
Borghi, Daniela ;
Bossi, Roberto Tiberio ;
Brasca, Maria Gabriella ;
Cappella, Paolo ;
Caruso, Michele ;
Ceccarelli, Walter ;
Ciavolella, Antonella ;
Cristiani, Cinzia ;
Croci, Valter ;
De Ponti, Anna ;
Fachin, Gabriele ;
Ferguson, Ronald Dale ;
Lansen, Jacqueline ;
Moll, Jurgen Karl ;
Pesenti, Enrico ;
Posteri, Helena ;
Perego, Rita ;
Rocchetti, Maurizio ;
Storici, Paola ;
Volpi, Daniele ;
Valsasina, Barbara .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (09) :3532-3551
[4]
CARUSO M, 2008, Patent No. 2008074788
[5]
DAY W, 2005, ONCOGENE, V24, P215
[6]
Synthesis and SAR of substituted tetrahydrocarbazole derivatives as new NPY-1 antagonists [J].
Di Fabio, R ;
Giovannini, R ;
Bertani, B ;
Borriello, M ;
Bozzoli, A ;
Donati, D ;
Falchi, A ;
Ghirlanda, D ;
Leslie, CP ;
Pecunioso, A ;
Rumboldt, G ;
Spada, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) :1749-1752
[7]
A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors [J].
Garland, Linda L. ;
Taylor, Charles ;
Pilkington, Deborah L. ;
Cohen, Jan L. ;
Von Hoff, Daniel D. .
CLINICAL CANCER RESEARCH, 2006, 12 (17) :5182-5189
[8]
Progress in the Mitsunobu reaction. A review [J].
Hughes, DL .
ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 1996, 28 (02) :127-164
[9]
The polo-like protein kinases Fnk and Snk associate with a Ca2+- and integrin-binding protein and are regulated dynamically with synaptic plasticity [J].
Kauselmann, G ;
Weiler, M ;
Wulff, P ;
Jessberger, S ;
Konietzko, U ;
Scafidi, J ;
Staubli, U ;
Bereiter-Hahn, J ;
Strebhardt, K ;
Kuhl, D .
EMBO JOURNAL, 1999, 18 (20) :5528-5539
[10]
Polo-like kinase-1 controls proteasome-dependent degradation of claspin during checkpoint recovery [J].
Mamely, Ivan ;
van Vugt, Marcel A. T. M. ;
Smits, Veronique A. J. ;
Semple, Jennifer I. ;
Lemmens, Bennie ;
Perrakis, Anastassis ;
Medema, Rene H. ;
Freire, Raimundo .
CURRENT BIOLOGY, 2006, 16 (19) :1950-1955